Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies



Cyberonics Names Bruce H. KenKnight, Ph.D. Vice President, Emerging Therapies (via PR Newswire)

HOUSTON, Jan. 9, 2013 /PRNewswire/ — Cyberonics, Inc. (NASDAQ: CYBX) today announced that Bruce H. KenKnight , Ph.D., joined the company as its Vice President, Emerging Therapies, effective on January 1, 2013.  Dr. KenKnight will lead all of the company’s emerging therapies programs, including the…



- in: Categories